JPS5758627A - Proteinic biosynthetic accelerator - Google Patents

Proteinic biosynthetic accelerator

Info

Publication number
JPS5758627A
JPS5758627A JP55132795A JP13279580A JPS5758627A JP S5758627 A JPS5758627 A JP S5758627A JP 55132795 A JP55132795 A JP 55132795A JP 13279580 A JP13279580 A JP 13279580A JP S5758627 A JPS5758627 A JP S5758627A
Authority
JP
Japan
Prior art keywords
proteinic
aconitine
biosynthetic
accelerator
hypaconitine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP55132795A
Other languages
Japanese (ja)
Other versions
JPS6366289B2 (en
Inventor
Hiroshi Hikino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP55132795A priority Critical patent/JPS5758627A/en
Publication of JPS5758627A publication Critical patent/JPS5758627A/en
Publication of JPS6366289B2 publication Critical patent/JPS6366289B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Fodder In General (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: A proteinic biosynthetic accelerator, containing an aconitine alkaloid as an active constituent, and useful for accelerating the biosynthesis of proteins.
CONSTITUTION: A proteinic biosynthetic accelerator containing one of aconitine alkaloid selected from the group consisting of mesacorntine, aconitine and hypaconitine or a mixture of two or more thereof. Experiments on the measurement of the amount incorporated of 3H-leucine into hepatic proteins showed that the proteinic biosynthesis was significantly accelerated by the administration of an aconite root containing the mesaconitine, aconitine, hypaconitine or an aconitine alkaloid or a processed aconite root. The daily dose at the proteinic biosynthetic accelerator is 0.1g aconite root powder, 10g processed aconite powder, 0.12mg mesaconitine, 0.15mg aconitine and 0.45mg hypaconitine for an adult by the oral administration.
COPYRIGHT: (C)1982,JPO&Japio
JP55132795A 1980-09-26 1980-09-26 Proteinic biosynthetic accelerator Granted JPS5758627A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55132795A JPS5758627A (en) 1980-09-26 1980-09-26 Proteinic biosynthetic accelerator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55132795A JPS5758627A (en) 1980-09-26 1980-09-26 Proteinic biosynthetic accelerator

Publications (2)

Publication Number Publication Date
JPS5758627A true JPS5758627A (en) 1982-04-08
JPS6366289B2 JPS6366289B2 (en) 1988-12-20

Family

ID=15089730

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55132795A Granted JPS5758627A (en) 1980-09-26 1980-09-26 Proteinic biosynthetic accelerator

Country Status (1)

Country Link
JP (1) JPS5758627A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995025517A1 (en) * 1994-03-18 1995-09-28 Tsumura & Co. Remedy for infectious diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995025517A1 (en) * 1994-03-18 1995-09-28 Tsumura & Co. Remedy for infectious diseases

Also Published As

Publication number Publication date
JPS6366289B2 (en) 1988-12-20

Similar Documents

Publication Publication Date Title
PT79615B (en) Process for the preparation of analgesic compositions containing 17-(cyclopropylmethyl)-x-(1,1-dimethyethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinane-7-methanol and 1-n-alyl-14-hydroxynordihydromorphinone
IL67920A0 (en) New derivatives of 3-keto delta 4,9,19-nor steroids,their preparation,their application as medicaments,the compositions containing them and the new intermediates obtained
PT76745A (en) Process for the preparation of imidazo-<1,2-c>pyrazolio-<3,4-e>-pyrimidines with antipsychotic effect and pharmaceutical compositions therewith
ES8702137A1 (en) Process for preparation of a solid form for oral use based on nifedipine with controlled release of the active substance.
JPS51143137A (en) Ultrasonic carbureter
JPS5758627A (en) Proteinic biosynthetic accelerator
DE3377491D1 (en) 2,3,4-trinor-1,5-inter-m-phenylene-prostacyclin-i2 analogues, process for the preparation thereof and pharmaceutical compositions containing the same
PT76870B (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
JPS523023A (en) Preparation of amino acid ester of organopolysiloxane
JPS57106618A (en) Anticancer agent consisting of polyprenyl compound
IL56913A0 (en) Steroid spiro oxazolidinone derivatives,their preparation and pharmaceutical compositions containing them
EP0162924A4 (en) 5-fluorouracil derivatives and medicinal preparation containing same.
DE3160797D1 (en) 11-alpha-amino androstanes, pharmaceutical compositions containing them and processes for their preparation
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
JPS525769A (en) Preparation of 3-substituted pyrolidine derivatives
IL68192A0 (en) 4h-furo(3,2-b)indoles,their preparation and pharmaceutical compositions containing them
JPS5739739A (en) Green tea containing calcium
JPS5346950A (en) (54)1-acetylaminotricyclo(4,3,1,12,5)undecane and its preparation
IL68572A (en) Fluoroalkyl-1'-di-halobenzyl-spiro(imidazolidine-4,3'-indoline)-2,2',5-triones,their preparation and pharmaceutical compositions containing them
ZA813678B (en) 4-(-1-piperazinyl)-furo (3,2-c)pyridine derivatives,processes for their preparation and pharmaceutical compositions containing same
JPS5569510A (en) Carcinostatic agent
ES8401072A1 (en) Compound 3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxopurine-7-acetyl-8-(2-phenylethyl)-1-oxa-3,8-diazaspiro-(4,5)decan-2-one and a process of preparation thereof
AU567183B2 (en) Pharmaceutical compositions of gonadoliberin or gonadoliberin agonists
JPS53139731A (en) Hypotensive agent containing methyl reserpate
JPS5318551A (en) 4-homoprotoadamantane and its preparation